Gala Health Review: Flat Pricing and Happy Reviewers — And 22 Complaints It Never Answered

What Is Gala Health?

Gala Health, trading online as Gala GLP-1, is a telehealth brand marketed primarily to women, selling compounded GLP-1/GIP medication for weight loss alongside a lower-dose 'microdosing' protocol and a hormone replacement therapy line. You complete an online assessment, a provider reviews it, and medication ships to you with delivery included.

The core pricing is genuinely well-designed: $179 a month covering all doses, with free delivery and a provider visit included. Holding the price flat as you titrate is the right structure and removes the bait-and-switch built into most compounded pricing. The microdosing protocol starts from $149/month. Both are quoted against a yearly subscription.

Customer sentiment is good on one platform. Gala holds roughly 4.4 to 4.6 stars across about 1,076 to 1,100 Trustpilot reviews, with reviewers commonly citing appetite suppression and steady weight loss. Negative Trustpilot feedback clusters on shipping delays and communication gaps rather than the medication itself.

The corporate record is a different picture entirely. The BBB lists the operator as AI Coaching Inc., d/b/a Gala GLP-1, at 1007 N Orange St Fl 4 # 2920, Wilmington, DE 19801, with a file opened on 17 October 2025. It is not accredited and carries an F rating, for the explicitly stated reason: 'Failure to respond to 22 complaint(s) filed against business.' All twenty-two remain unanswered.

Medications Offered & Pricing

Prices are as published on 6 August 2026. The flat-across-doses structure is real and is the best thing about Gala's pricing. But both rates are quoted against a yearly subscription, and the site simultaneously says you can 'cancel anytime' — two claims that do not obviously coexist. Given that twenty-two BBB complaints against this company sit unanswered, including at least one alleging a refused $600 refund, get the actual commitment length and cancellation terms confirmed in writing before you pay anything.

Brand-Name or Compounded?

Everything in the weight-loss line is compounded. Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, efficacy or manufacturing quality. There is no brand-name Wegovy, Ozempic, Mounjaro or Zepbound option here.

There is a specific compliance gap worth flagging. Gala's microdosing page, which we reviewed on 6 August 2026, carried no FDA-approval disclaimer at all. For a page selling a compounded, unapproved preparation and making health claims, that absence is notable — most competitors, including several we rate poorly, at least manage the disclaimer.

The claims on that page are the bigger problem. It states an 'Average 15–20% body weight reduction in clinical data' over six months, and then, separately, that 'Some patients lose modest weight (5–10 lbs over 6 months).' Those two statements describe wildly different outcomes and cannot both characterise the same protocol. The 15–20% figure is the published result from full-dose tirzepatide trials of the branded medicine — not from any study of a microdosed compounded preparation. Placing branded full-dose trial data on a microdosing sales page is precisely the construction the FDA cited as misbranding in a February 2026 warning letter to another telehealth company, and that the National Advertising Division ruled unsubstantiated against a third in December 2025.

The microdosing protocol itself is marketed for 'improved insulin sensitivity, steadier energy, better sleep, and a quieter inflammatory baseline' and for 'longevity and metabolic resilience.' There is no clinical outcome evidence establishing those benefits from microdosed GLP-1 therapy. Microdosing is a commercial protocol, not an evidence-based regimen — it may reduce side effects, and it may equally reduce effect.

The Consultation Process

Eligibility

• •Eligibility is assessed by a licensed provider from your online questionnaire. No specific BMI threshold is published on the pages we reviewed.
• •States served are not published. Confirm availability before subscribing.
• •GLP-1 medicines are contraindicated in people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, and must not be used in pregnancy or while trying to conceive. Because Gala markets primarily to women, that second point deserves emphasis: if you are pregnant, trying to conceive or breastfeeding, GLP-1 therapy is not appropriate.
• •Clinician judgement is required for anyone with a history of pancreatitis, gallbladder disease, severe gastrointestinal disease including gastroparesis, or diabetic retinopathy.
• •Common side effects are gastrointestinal — nausea, vomiting, diarrhoea, constipation and reflux — usually worst after a dose increase. Less common but serious risks include pancreatitis, gallbladder disease and dehydration-related kidney injury.
• •Gala's microdosing protocol is explicitly marketed to people 'already lean or near goal weight.' Prescribing a GLP-1 to someone at or near a healthy weight for energy, sleep or 'longevity' benefits is not an established medical use, and anyone considering it should discuss the risk-benefit balance with an independent clinician rather than the seller.

Provider Involvement, Labs & Pharmacy

Shipping & Support Services

Free delivery is included in the subscription price. Shipping delays with poor status communication are the most common complaint in Gala's negative Trustpilot reviews. For a temperature-sensitive weekly injectable, inspect deliveries on arrival and do not use medication that arrives warm.

• •Flat $179/mo price covering every dose — no increase as you titrate
• •Provider visit included in the subscription
• •Free delivery included
• •Lower-cost microdosing option from $149/mo
• •Hormone replacement therapy available as a separate line
• •Around 4.4–4.6 stars across roughly 1,100 Trustpilot reviews
• •Women-focused positioning and messaging

Fees, Cancellation & Refunds

Insurance & HSA/FSA

Pros & Cons

Who Gala Health May Be Best For

• •Very few readers, on the current record — the unanswered complaint history outweighs the pricing advantage
• •Existing customers who are happy with the treatment and simply want to understand the company's record
• •Anyone who has confirmed the commitment length and refund terms in writing and is paying with a disputable card

Limitations

• •Twenty-two unanswered complaints is the defining fact. An F from the BBB for 'failure to respond' is not a rating that reflects unhappy customers — plenty of companies accumulate complaints. It reflects a company that does not engage with them at all. If your medication does not arrive, your card is charged after you cancel, or you are refused a refund, the public record shows no route to resolution.
• •The microdosing page is the part we would most want taken down and rewritten. Advertising 'Average 15–20% body weight reduction in clinical data' for a microdosing protocol borrows the headline result from full-dose tirzepatide trials of an FDA-approved medicine that Gala does not sell. That the same page elsewhere concedes patients lose '5–10 lbs over 6 months' shows the company knows the real expectation. Placing the larger number where a buyer will see it first is the problem, and it is the same construction that drew an FDA misbranding letter to a competitor in February 2026.
• •No FDA disclaimer on that page compounds it. Selling an unapproved compounded preparation with health claims and no statement of its regulatory status falls below what even the weakest operators in this market manage.
• •The commitment terms are unresolved in Gala's own marketing. A 'yearly subscription' price alongside 'cancel anytime' cannot both govern, and with no published refund policy and no answered complaints, the reader has no way to find out which applies until it matters. That is the worst possible combination for a cash-pay annual commitment.
• •Trading as AI Coaching Inc. is worth noticing. It is not disqualifying — plenty of companies operate under an unrelated registered name — but a coaching corporation prescribing compounded injectable medication is a structure worth understanding before you hand it a year's payment.
• •In fairness: the flat-dose pricing is genuinely good, bundling the provider visit and shipping is the right approach, and around 1,100 Trustpilot reviewers report a positive treatment experience. Most Gala customers evidently get their medication and lose weight. This rating reflects what happens to the ones who do not.

Alternatives to Consider

Frequently Asked Questions

Our Verdict

Gala Health has built the pricing model correctly. $179 a month covering every dose, with the provider visit and delivery included and no increase as you titrate, is better structured than most of this market, and roughly 1,100 Trustpilot reviewers rating it around 4.5 stars means plenty of customers get their medication and lose weight without incident.

Everything else points the other way. An F rating from the Better Business Bureau for failing to respond to twenty-two complaints — all still unanswered — means there is no demonstrated path to resolution when something goes wrong, and a complainant alleging a refused $600 refund on a service never started suggests what going wrong can look like. No refund policy is published. The commitment is described as a yearly subscription in one place and cancel-anytime in another.

The microdosing marketing is the part we would call misleading rather than merely weak. Advertising a 15–20% average body weight reduction 'in clinical data' on a page selling a low-dose compounded protocol takes the headline from full-dose trials of an approved branded medicine Gala does not sell — while the same page quietly concedes the real range is 5–10 lbs. Doing that with no FDA disclaimer on the page is worse again.

We rate Gala Health 1.9 out of 5. Good pricing architecture and a satisfied customer base cannot offset a company that answers none of its formal complaints and markets a low-dose protocol using someone else's full-dose trial results. If the flat-dose pricing is what appeals, CoreAge Rx at $99/mo and CallonDoc at $89/mo are cheaper with far better records; if the women-focused positioning is the draw, EllieMD or Midi Health are the comparisons to make.

This review is informational only and is not medical advice. Compounded GLP-1s are not FDA-approved and have not been evaluated for safety, efficacy or quality, and GLP-1 medicines must not be used in pregnancy or while trying to conceive. Speak to a licensed clinician about whether treatment is appropriate for you before starting, changing or stopping any medication.